---
title: frogs
description: >-
  Analyze compound-target annotations and gene signatures to connect molecules
  with pathway activity.
tags:
  - frogs
---

Connect molecules to biology by integrating compound-target annotations with gene expression signatures to score how compounds modulate biological pathways. Reach for frogs when you have hits or candidates and want mechanism-of-action insight, pathway-based prioritization, or repositioning hypotheses rather than raw binding data. It sits downstream of screening and generative chemistry, translating molecular targets into pathway-level effects. See the [Cell & Tissue overview](/docs/cell-tissue) for where this fits.

> **Not available in chat**

> FRoGS is deprecated on the platform and its Modal backend has been taken offline — it is not registered with the orchestrator, so chat cannot call it. A still-registered legacy form of the tool also faked its results (returning mock predictions and reporting `SUCCESS` regardless of input), so treat any historical FRoGS output as unverified. There is no direct replacement on the platform for compound-target deconvolution from gene expression signatures.

## frogs pathway analysis integration in .bloom* platform

frogs provides comprehensive pathway impact analysis by integrating compound-target interactions with gene expression signatures. Through .bloom*'s webapp, you can analyze how compounds modulate biological pathways and prioritize candidates based on mechanism-of-action insights.

## Citations

> Chen H, King FJ, Zhou B, Wang Y, Canedy CJ, Hayashi J, Zhong Y, Chang MW, Pache L, Wong JL, Jia Y, Joslin J, Jiang T, Benner C, Chanda SK, Zhou Y. Drug target prediction through deep learning functional representation of gene signatures. *Nat Commun*. 2024;15:1853. doi: [10.1038/s41467-024-46089-y](https://doi.org/10.1038/s41467-024-46089-y)

> Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. *Proc Natl Acad Sci USA*. 2005 Oct 25;102(43):15545-50. doi: [10.1073/pnas.0506580102](https://doi.org/10.1073/pnas.0506580102)

> Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. *Nucleic Acids Research*. 2000 Jan 1;28(1):27-30. doi: [10.1093/nar/28.1.27](https://doi.org/10.1093/nar/28.1.27)

> Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. *Nature Genetics*. 2000 May;25(1):25-9. doi: [10.1038/75556](https://doi.org/10.1038/75556)

## Resources

- **Pathway databases**: [KEGG](https://www.kegg.jp), [Reactome](https://reactome.org), [Gene Ontology](http://geneontology.org)
- **Expression databases**: [GEO](https://www.ncbi.nlm.nih.gov/geo/), [ArrayExpress](https://www.ebi.ac.uk/arrayexpress/)
- **ARCHS4**: [https://maayanlab.cloud/archs4/](https://maayanlab.cloud/archs4/) - Uniformly processed RNA-seq gene expression data

## Webapp pathway analysis capabilities

### Input data integration

**Compound-target data:**
- **Direct upload**: CSV files with compound-target annotations
- **Previous jobs**: Integration with screening results and predictions
- **Database integration**: PubChem, ChEMBL, and custom target databases
- **Batch processing**: Multiple compounds with associated targets

**Gene signature data:**
- **Expression profiles**: Differential gene expression signatures
- **Pathway databases**: GO, KEGG, Reactome, and custom pathways
- **Target annotations**: Gene targets associated with compounds
- **Multi-omics data**: Integration of transcriptomics and proteomics

### Analysis methodology

**Signature embedding:**
- **Gene expression**: Transform expression profiles into pathway signatures
- **Target mapping**: Link compound targets to biological pathways
- **Pathway scoring**: Calculate compound impact on pathway activity
- **Mechanism inference**: Identify likely modes of action

**Pathway impact assessment:**
- **Enrichment analysis**: Statistical assessment of pathway modulation
- **Compound ranking**: Prioritization based on pathway relevance
- **Target-pathway mapping**: Connect molecular targets to biological effects
- **Confidence scoring**: Reliability assessment of predictions

## When to use frogs in drug discovery

### Mechanism-of-action studies

**Target deconvolution:**
- Identify pathways modulated by hit compounds
- Understand off-target effects and polypharmacology
- Link phenotypic screening to molecular mechanisms
- Generate hypotheses for compound optimization

**Compound prioritization:**
- Rank compounds based on pathway selectivity
- Identify compounds targeting therapeutically relevant pathways
- Assess safety implications through pathway analysis
- Guide selection of compounds for preclinical studies

**Drug repositioning:**
- Identify new indications for known compounds
- Analyze pathway effects across different therapeutic areas
- Compare compound profiles with approved drugs
- Generate mechanistic hypotheses for repurposing

### Systems pharmacology applications

**Network pharmacology:**
- Analyze compound effects on biological networks
- Identify key nodes and pathways in disease mechanisms
- Assess compound combinations and synergistic effects
- Model complex drug-target-pathway relationships

**Toxicity prediction:**
- Identify potential toxicity pathways and mechanisms
- Assess off-target liabilities through pathway analysis
- Predict adverse event profiles based on pathway modulation
- Generate safety hypotheses for preclinical testing

## Webapp interface and workflow

### Data preparation and upload

**Compound data:**
- Upload compound lists with target annotations
- Validate compound identifiers and target information
- Preview data structure and completeness
- Handle missing data and formatting issues

**Signature data:**
- Import gene expression signatures from experiments
- Select appropriate pathway databases and annotations
- Configure analysis parameters and thresholds
- Preview signature quality and coverage

### Analysis configuration

**Pathway selection:**
- Choose from curated pathway databases (GO, KEGG, Reactome)
- Upload custom pathway definitions and gene sets
- Select pathway categories relevant to research question
- Configure pathway size and enrichment thresholds

**Scoring parameters:**
- **Statistical methods**: Choose enrichment analysis approaches
- **Significance thresholds**: Set p-value and FDR cutoffs
- **Scoring algorithms**: Select pathway impact calculation methods
- **Confidence filters**: Apply quality thresholds for results

### Results visualization and exploration

**Pathway impact maps:**
- **Heatmap visualization**: Compound-pathway interaction matrices
- **Network diagrams**: Pathway relationships and compound connections
- **Enrichment plots**: Statistical significance representations
- **Target-pathway linkages**: Molecular to biological effect mapping

**Compound ranking:**
- **Pathway-based prioritization**: Rank compounds by pathway relevance
- **Mechanism clustering**: Group compounds by similar pathway effects
- **Selectivity analysis**: Assess pathway selectivity vs. promiscuity
- **Safety profiling**: Identify potential toxicity pathways

**Interactive exploration:**
- **Pathway details**: Drill down into specific pathway mechanisms
- **Compound profiles**: View detailed pathway effects for individual compounds
- **Comparative analysis**: Side-by-side comparison of compound profiles
- **Export capabilities**: Generate reports and visualizations

## Integration with .bloom* ecosystem

### Upstream data sources

**Compound data:**
- **Virtual screening**: Hits from DiffDock and molecular docking
- **Generative chemistry**: Compounds from DeepPurpose and AiZynthFinder
- **Experimental data**: HTS results and phenotypic screening
- **Literature mining**: Compound-target associations from publications

**Biological data:**
- **Gene expression**: Transcriptomics data from experiments
- **Target databases**: Protein target annotations and interactions
- **Pathway databases**: Curated biological pathway collections
- **Omics data**: Multi-omics datasets for comprehensive analysis

### Downstream applications

**Drug design:**
- **Mechanism-guided optimization**: Use pathway insights for SAR
- **Target selection**: Identify optimal targets based on pathway effects
- **Combination therapy**: Assess synergistic pathway combinations
- **Biomarker identification**: Link pathway effects to clinical endpoints

**Experimental planning:**
- **Assay development**: Design pathway-specific functional assays
- **Animal models**: Select relevant disease models based on pathways
- **Clinical trials**: Identify pathway biomarkers for patient stratification
- **Translational research**: Bridge preclinical to clinical pathway effects

## Analysis quality and performance

### Data quality assurance

**Input validation:**
- **Compound verification**: Validate chemical structures and identifiers
- **Target validation**: Check protein target annotations and quality
- **Signature assessment**: Evaluate gene expression data quality
- **Pathway verification**: Confirm pathway definitions and gene sets

**Analysis reliability:**
- **Statistical robustness**: Assess enrichment analysis significance
- **Biological relevance**: Validate pathway assignments and mechanisms
- **Prediction confidence**: Provide uncertainty estimates for results
- **Cross-validation**: Compare results across different methods

### Performance optimization

**Computational efficiency:**
- **Batch processing**: Analyze multiple compounds simultaneously
- **Parallel computation**: Utilize distributed processing capabilities
- **Memory optimization**: Handle large pathway databases efficiently
- **Result caching**: Speed up repeated analyses

**Scalability considerations:**
- **Large datasets**: Process thousands of compounds and pathways
- **High-throughput screening**: Analyze screening libraries efficiently
- **Real-time analysis**: Provide immediate results for interactive exploration
- **Resource management**: Optimize for different computational environments

## Best practices for pathway analysis

### Data preparation

**Compound curation:**
- Ensure consistent compound identifiers across datasets
- Validate target annotations with current databases
- Include relevant physicochemical properties for context
- Document compound sources and quality information

**Signature quality:**
- Use high-quality gene expression data with appropriate controls
- Apply appropriate normalization and quality control measures
- Consider batch effects and technical variability
- Document experimental conditions and biological context

### Analysis configuration

**Pathway selection:**
- Choose pathway databases relevant to therapeutic area
- Consider pathway size and specificity for analysis goals
- Include both general and specific pathway categories
- Validate pathway definitions against current knowledge

**Parameter optimization:**
- Set appropriate statistical thresholds for significance
- Consider multiple testing corrections for large analyses
- Balance sensitivity and specificity based on research goals
- Document parameter choices for reproducibility

### Result interpretation

**Biological context:**
- Interpret results in context of known biology and disease mechanisms
- Consider tissue and cell type specificity of pathway effects
- Account for species differences in pathway conservation
- Cross-reference with literature and experimental data

**Statistical considerations:**
- Understand p-value and enrichment score interpretations
- Consider pathway size effects on statistical significance
- Account for multiple testing in result interpretation
- Validate key findings with orthogonal approaches

### Research reproducibility

**Documentation:**
- Record all analysis parameters and data sources
- Document pathway database versions and definitions
- Preserve analysis workflows for replication
- Generate comprehensive analysis reports

**Collaboration:**
- Share pathway analysis results with team members
- Generate publication-ready figures and tables
- Document methods for peer review and validation
- Maintain searchable analysis archives

## FAQ

### What inputs do I need?

  Provide compound lists, target annotations, and gene signatures (e.g., GO/ARCHS4-style embeddings) plus any pathway sets you want evaluated.

### How is quality controlled?

  frogs validates input formats, checks for missing targets, and reports any dropped signatures so you can correct them before re-running.

### What outputs are generated?

  Ranked pathway associations, compound-to-pathway scores, and downloadables for further analysis or visualization.

## Read next